NCT00792103View on ClinicalTrials.gov

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

PHASE3CompletedINTERVENTIONAL

Enrollment

198

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Migraine Disorders

Interventions

DRUG

NP101

NP101 study patch 4 hour application

Trial Locations (34)

Unknown

Phoenix

Little Rock

Newport Beach

San Francisco

Santa Monica

Fairfield

Ocala

Palm Beach Gardens

Sunrise

Atlanta

Columbus

Decatur

Savannah

Chicago

Ann Arbor

Kalamazoo

Springfield

St Louis

Mount Vernon

Plainview

Greensboro

West Chester

Oklahoma City

Philadelphia

Pittsburgh

Wynnewood

Memphis

Nashville

Dallas

Houston

San Antonio

Alexandria

Virginia Beach

Seattle

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NuPathe Inc.

INDUSTRY